PacBio Announces Record Preliminary Fourth Quarter 2021

Jan 11, 2022 · Expect preliminary fourth quarter revenue of approximately $36.0 million, representing an increase of approximately 33% compared with $27.1 million for the fourth …

33%
OFF

PacBio Announces Record Preliminary Fourth Quarter 2021

2 weeks from now

Jan 11, 2022 · Expect preliminary fourth quarter revenue of approximately $36.0 million, representing an increase of approximately 33% compared with $27.1 million for the fourth …

globenewswire.com

33%
OFF

PacBio Announces Fourth Quarter And Fiscal Year 2021 Financial …

2 weeks from now

Feb 15, 2022 · Fourth quarter results reflect record revenue. Revenue of $36.0 million, a 33% increase compared with $27.1 million in the prior year period. Placed a record 48 Sequel II/IIe …

rag.media

65%
OFF

PacBio's 2021 Full-year Revenue Grows 65%, Will Upgrade ... - 頭條匯

2 weeks from now

PacBio's fourth-quarter 2021 revenue totaled $36 million, up 33% year-over-year; full-year 2021 revenue was $130.5 million, up 65% year-over-year. At the same time, PacBio announced that …

min.news

33%
OFF

PacBio Announces Preliminary Fourth Quarter And Full Year Revenue

2 weeks from now

1 day ago · The preliminary Q4 results reveal concerning trends for PacBio, with revenue declining 33% year-over-year to $39.2 million.Most notably, instrument revenue dropped …

stocktitan.net

$15
OFF

PacBio Announces Preliminary Fourth Quarter And Full Year Revenue

2 weeks from now

22 hours ago · Preliminary instrument revenue for the fourth quarter of 2024 is expected to be approximately $15.3 million, compared with $35.1 million for the fourth quarter of 2023. …

businessinsider.com

$39
OFF

PacBio Announces Preliminary Q4 Revenue Of $39.2M

2 weeks from now

22 hours ago · PacBio (NASDAQ:PACB) on Tuesday announced preliminary unaudited revenue for the fourth quarter of 2024 and full year 2024 of $39.2 million and $154 million, representing …

seekingalpha.com

$39
OFF

PacBio Announces Preliminary Q4 Revenue Of $39.2M - MSN

2 weeks from now

PacBio (NASDAQ:PACB) on Tuesday announced preliminary unaudited revenue for the fourth quarter of 2024 and full year 2024 of $39.2 million and $154 million, representing a year-over …

msn.com

$5
OFF

PacBio Announces Preliminary Fourth Quarter And Full Year Revenue

2 weeks from now

22 hours ago · Preliminary service and other revenue for the fourth quarter of 2024 is expected to be approximately $5.1 million, compared with $4.4 million for the fourth quarter of 2023. Total …

manilatimes.net

2%
OFF

New Jersey MarketBeats | US | Cushman & Wakefield

2 weeks from now

Oct 8, 2024 · Northern New Jersey's office vacancy rate climbed to 23.2% by the end of the third quarter of 2024, up 160 basis points year-over-year. ... With your permission we and our …

cushmanwakefield.com

$2
OFF

Kazia Therapeutics Announces Closing Of $2.0 Million Registered …

2 weeks from now

1 day ago · PacBio Announces Preliminary Fourth Quarter and Full Year Revenue. RKT. ... which was licensed from Evotec SE in April 2021. Preclinical data has shown EVT801 to be active …

stocktitan.net

$5
OFF

PacBio Announces Preliminary Fourth Quarter And Full Year

2 weeks from now

22 hours ago · Preliminary service and other revenue for the fourth quarter of 2024 is expected to be approximately $5.1 million, compared with $4.4 million for the fourth quarter of 2023. Total …

globenewswire.com

FAQs about PacBio Announces Record Preliminary Fourth Quarter 2021 Coupon?

How did PacBio perform in Q4 2024?

MENLO PARK, Calif., Jan. 14, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced preliminary unaudited revenue for the fourth quarter of 2024 and full year 2024 of $39.2 million and $154.0 million representing a year-over-year decline of 33% and 23%, respectively. ...

How much cash will PacBio have in 2024?

Total preliminary unrestricted cash, cash equivalents, and investments balance as of December 31, 2024, is expected to be approximately $390 million. PacBio is scheduled to present at the 43 rd Annual J.P. Morgan Healthcare Conference on January 14, 2025, at 4:30 p.m. Pacific Time. ...

When is PacBio presenting at JP Morgan Healthcare Conference 2025?

PacBio is scheduled to present at the 43 rd Annual J.P. Morgan Healthcare Conference on January 14, 2025, at 4:30 p.m. Pacific Time. PacBio plans to make the presentation available on the Events & Presentations Section of PacBio's website at investor.pacificbiosciences.com. ...

Does PacBio have a website address?

The information posted on or that can be accessed through PacBio's website, including PacBio's updated corporate presentation, is not incorporated by reference into this press release, and the inclusion of PacBio's website address is an inactive textual reference only. ...

What does PacBio stand for?

About PacBio PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. ...